16
Participants
Start Date
December 31, 2011
Primary Completion Date
May 31, 2013
Study Completion Date
May 31, 2013
cabazitaxel XRP6258
Pharmaceutical form: solution for infusion Route of administration: intravenous
Investigational Site Number 410001, Seoul
Lead Sponsor
Sanofi
INDUSTRY